MORRISVILLE, N.C., August 15, 2023 — Premier Research has strategically expanded its Clinical Development Services team to enhance therapeutic strategy, special patient population expertise, and risk-based clinical development service offerings for biotech and medtech sponsors.
“With the patient experience at the forefront, our team is equipped to analyze study-specific challenges and provide tailored strategies to get assets to market quickly with minimal risk. The addition of new subject matter experts strengthens these capabilities and will undoubtedly enhance the value that we offer our sponsors.”
Recently joining Premier Research’s team of Clinical Development experts are Nicole Stansbury, Leslie Wetherell, Adam Simmons, and Dr. Brandi Howard.
- Nicole Stansbury, Senior Vice President, Global Clinical Operations, has worked in the CRO industry for more than 25 years and has extensive experience leading and implementing clinical operations, central monitoring, and risk-based monitoring strategy. Understanding that our sponsors are navigating complex and often unprecedented development pathways, Stansbury’s focus is to decrease the time, cost, complexity, and risk of delivering clinical research. She will oversee operational strategy and delivery, study start-up, central monitoring, site management and risk-based monitoring and will be instrumental in driving continuous improvement to Premier Research’s clinical operations processes. Stansbury’s experience includes serving as co-lead for the Association of Clinical Research Organizations Risk-Based Monitoring (ACRO RBM) Working Group, working with TransCelerate and the FDA since 2014.
- Leslie Wetherell, Executive Director, Program Strategy, Rare Disease and Pediatrics is a clinical research professional with over 25 years of experience working with biotech and pharmaceutical companies to propel global drug development, with a focus in rare disease. Leveraging therapeutic and operational expertise, Wetherell will construct creative strategies focused on key results in rare disease and pediatric studies, most notably enrollment challenges due to hard-to-reach patient populations. Wetherell’s patient-centric and milestone-driven approach will produce strategic efficiencies that support timely program delivery.
- Adam Simmons, Executive Director, Program Strategy, Neuroscience has over 20 years of experience in drug and device research working for pharmaceutical companies and academic medical centers. He has over 30 publications across neuroscience indications and research methodologies. Simmons extensive experience includes overseeing clinical trials conducted in more than 25 countries across North and South America, Europe, and Asia Pacific. Using his expertise in neuropharmacology, Simmons will provide strategic planning and coordination to support clinical research projects and consultative needs.
- Brandi Howard, Ph.D., Executive Director, Program Strategy, Women’s Health, joins Premier with 20 years of experience in medical affairs and clinical development specialized in reproductive and women’s health. Dr. Howard has held senior positions at biotech and pharma companies in the women’s health space, building and leading large, global teams. She has a keen understanding of the unique challenges sponsors face not only surrounding clinical trial design and execution, but also in regard to product approval and launch strategy. Recognizing the challenges of this underserved area of research, Dr. Howard is prepared to assess new technologies and regulatory pathways as well as commercial viability to design and implement smarter, safer, meaningful clinical trials that enable innovation to reach women and their families.
About Premier Research
Premier Research, a clinical research, product development, and consulting company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.
As a global company, Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.
Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.